This cutting-edge long-read sequencing instrument offers exciting new capabilities. Its applications span a wide range, including de novo genome assembly for both eukaryotic and prokaryotic species, the most cost-effective genome resequencing using long reads, sequencing of long amplicons including full-length 16S, and full-length mRNA sequencing from bulk or single-cell RNAseq samples.
The standout advantage of the REVIO lies in its significantly reduced sequencing cost. Compared to the Sequel, it produces three times the data for the same cost, making it an best choice for researchers for their long-reads needs.
We eagerly anticipate discussing how long-read sequencing can enhance your research endeavors. Feel free to reach out for further details! 😊
